Q Bio (Series C)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$149,999,999
Company Info
Founders
Jeffrey Kaditz
Market
Healthcare & Wellness
Coinvestors
Andreessen Horowitz,Khosla Ventures
Company Description

On a mission to build the first Clinical Digital Twin Platform and make it accessible to everyone. On a mission to build the first Clinical Digital Twin Platform and make it accessible to everyone